画像誘導治療システム市場：現状分析および予測（2022年～2028年）

世界の画像誘導治療システムの市場規模は、予測期間中に約6%という著しい成長率で拡大すると予測されています。画像誘導治療システムは、癌の放射線治療への取り組みの増加、慢性疾患の負担増、高齢者人口の増加など、さまざまな要因で拡大しています。

当レポートは、世界の画像誘導治療システム市場について調査し、市場の概要とともに、製品タイプ別、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場イントロダクション

第2章 調査方法または仮定

第3章 市場要約

第4章 エグゼクティブサマリー

第5章 COVID-19が画像誘導治療システム市場に与える影響

第6章 画像誘導治療システム市場の収益、2020年～2028年

第7章 製品タイプ別の市場洞察

• 超音波システム
• コンピューター断層撮影（CT）スキャナー
• 磁気共鳴画像法（MRI）
• 内視鏡
• 陽電子放出断層撮影法（PET）
• その他

第8章 用途別の市場洞察

• 脳神経外科
• 心臓手術
• 泌尿器科
• 整形外科
• その他

第9章 エンドユーザー別の市場洞察

• 病院
• 外来手術センター
• 診療所

第10章 地域別の市場洞察

• 北米
• 欧州
• アジア太平洋
• その他の地域

第11章 画像誘導治療システム市場の市場力学

• 市場促進要因
• 市場の課題
• 影響分析

第12章 画像誘導治療システムの市場機会

第13章 画像誘導治療システムの市場動向

第14章 需要側と供給側の分析

第15章 バリューチェーン分析

第16章 競合シナリオ

第17章 企業プロファイル

• Koninklijke Philips N.V.
• Medtronic Plc.
• Siemens Healthineers
• Analogic Corporation
• GE Healthcare
• Varian Medical Systems Inc.
• Brainlab AG
• Olympus Corporation
• Stryker
• FUJIFILM Holdings Corporation

第18章 免責事項

The global image guided therapy system market is expected to grow at a significant rate of around 6% during the forecast period. Image-guided therapy interrogates the use of any form of medical imaging to plan, perform, and evaluate surgical procedures and therapeutic interventions. Techniques for image-guided therapy aid in making surgeries less invasive and more precise. The most prevalent methods are Computed Tomography (CT) and Magnetic Resonance Imaging (MRI). These techniques are likewise upheld by ultrasound, angiography, careful route hardware, following devices, and joining programming.

Moreover, the image-guided therapy system is expanding due to a number of factors, including an increase in initiatives for cancer radiotherapy, an increase in the burden of chronic diseases, and an increase in the elderly population. According to the GLOBOCAN 2020 report from the International Agency for Research on Cancer, which estimated the incidence and mortality of 36 cancers in 185 countries worldwide, an estimated 19,292,789 new cases of cancer were diagnosed in 2020 and approximately 9,958,133 people died from cancer worldwide.

Koninklijke Philips N.V., Medtronic Plc., Siemens Healthineers, Analogic Corporation, GE Healthcare, Varian Medical Systems Inc., Brainlab AG, Olympus Corporation, Stryker, FUJIFILM Holdings Corporation Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst application, cardiac surgery category to witness robust CAGR during the forecast period"

Based on application, the market is segmented into neurosurgery, cardiac surgery, urology, orthopedic surgery, and others. Amongst, the cardiac surgery category is to witness higher CAGR during the forecast period owing to the growing number of chronic diseases such as cardiovascular diseases, cancer, and the rising geriatric populatioN.

Also, during the forecast period, the neurosurgery sector is likely to expand at a profitable rate. This market is primarily driven by the high prevalence of neurological disorders and the rising number of accident and trauma cases.

"Amongst end-user, the hospitals to hold a significant share in the market in 2020"

On the basis of end-user, the market is categorized into hospitals, ambulatory surgery centers, and clinics. Among these, the hospitals to hold a significant share of the market in 2020. This is mainly due to the availability of neurovascular devices, skilled healthcare professionals, and the safety & efficacy during the treatment procedures. Moreover, the growing patient pool suffering from neurovascular diseases such as brain aneurysms, and arteriovenous malformations are also contributing to the growth of this market during the forecast period. For instance, according to the Brain Aneurysms Foundation, about 30,000 people in the United States suffer a brain aneurysm rupture each year.

"North America to hold a significant share in the market"

For a better understanding of the market adoption of the IMAGE GUIDED THERAPY SYSTEM industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. Due to its well-established healthcare infrastructure, rapid adoption of advanced radiation therapies, and technological advancements. Additionally, the high demand for minimally invasive procedures and value-based reimbursements in this region will boost the growth of the image guided therapy system market due to the region's aging population and rising chronic disease cases. The well-established healthcare sector and the rising incidence of cancer are the primary drivers of the market's expansion in the United States.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The Global image guided therapy system market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the IMAGE GUIDED THERAPY SYSTEM MARKET
• 2.2. Research Methodology of the IMAGE GUIDED THERAPY SYSTEM MARKET
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE IMAGE GUIDED THERAPY SYSTEM MARKET

6 IMAGE GUIDED THERAPY SYSTEM MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY PRODUCT TYPE

• 7.1. Ultrasound Systems
• 7.2. Computed Tomography (CT) Scanners
• 7.3. Magnetic Resonance Imaging (MRI)
• 7.4. Endoscopes
• 7.5. Positron Emission Tomography (PET)
• 7.6. Others

8 MARKET INSIGHTS BY APPLICATION

• 8.1. Neurosurgery
• 8.2. Cardiac Surgery
• 8.3. Urology
• 8.4. Orthopedic Surgery
• 8.5. Others

9 MARKET INSIGHTS BY END-USER

• 9.1. Hospitals
• 9.2. Ambulatory Surgery Centers
• 9.3. Clinics

10 MARKET INSIGHTS BY REGION

• 10.1. North America
  • 10.1.1. U.S.
  • 10.1.2. Canada
  • 10.1.3. Rest of North America
• 10.2. Europe
  • 10.2.1. Germany
  • 10.2.2. U.K.
  • 10.2.3. France
  • 10.2.4. Italy
  • 10.2.5. Spain
  • 10.2.6. Rest of Europe
• 10.3. Asia-Pacific
  • 10.3.1. China
  • 10.3.2. Japan
  • 10.3.3. India
  • 10.3.4. Rest of Asia-Pacific
• 10.4. Rest of World

11 IMAGE GUIDED THERAPY SYSTEM MARKET DYNAMICS

• 11.1. Market Drivers
• 11.2. Market Challenges
• 11.3. Impact Analysis

12 IMAGE GUIDED THERAPY SYSTEM MARKET OPPORTUNITIES

13 IMAGE GUIDED THERAPY SYSTEM MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

• 14.1. Demand Side Analysis
• 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

• 16.1. Competitive Landscape
  • 16.1.1. Porters Fiver Forces Analysis

17 COMPANY PROFILED

• 17.1. Koninklijke Philips N.V.
• 17.2. Medtronic Plc.
• 17.3. Siemens Healthineers
• 17.4. Analogic Corporation
• 17.5. GE Healthcare
• 17.6. Varian Medical Systems Inc.
• 17.7. Brainlab AG
• 17.8. Olympus Corporation
• 17.9. Stryker
• 17.10. FUJIFILM Holdings Corporation

18 DISCLAIMER